Sahajanand Medical Technologies IPO
Closes Mon 19 Oct15–19 Oct 2026
Our IPO analysis
What stands out in the offer document
Every check we run on an offer document, and how often each one fires →
Sahajanand Medical Technologies GMP history
| When | GMP | Trackers |
|---|---|---|
| 15 Oct, 06:59 IST | ₹36 (+10.5%) | 2 |
| 14 Oct, 23:04 IST | ₹36 (+10.5%) | 2 |
| 14 Oct, 19:56 IST | ₹36 (+10.5%) | 2 |
| 14 Oct, 19:19 IST | ₹36 (+10.5%) | 2 |
| 14 Oct, 17:50 IST | ₹36 (+10.5%) | 2 |
| 14 Oct, 16:06 IST | ₹43 (+12.5%) | 2 |
| 14 Oct, 15:36 IST | ₹42 (+12.2%) | 2 |
| 14 Oct, 14:42 IST | ₹42 (+12.2%) | 2 |
| 14 Oct, 13:49 IST | ₹42 (+12.2%) | 2 |
| 14 Oct, 07:25 IST | ₹40 (+11.6%) | 2 |
| 14 Oct, 04:02 IST | ₹40 (+11.6%) | 2 |
| 14 Oct, 01:00 IST | ₹40 (+11.6%) | 2 |
Showing the latest 12 of 23 readings.
Grey-market premium is unregulated and self-reported: a sentiment read, not a promise. Today's GMP for every IPO · How often GMP has been right
Never miss an IPO like this
One free email when each IPO opens: subscription, GMP and the DRHP breakdown.
Latest update:
GMP +10.5% (₹36) · Price band ₹327–₹344 · Closes 19 Oct 2026 · Allotment 21 Oct 2026 (Confirmed) · Lists 23 Oct 2026 (Expected)
GMP is a compass, not a ruler: across the 60 IPOs we followed to listing it pointed the right way 80% of the time. The record
What Sahajanand Medical Technologies does
Sahajanand Medical Technologies Limited is an Indian medical device company focused on the research, development, manufacturing, and commercialization of Class III and Class C/D cardiovascular intervention products, including drug-eluting stents, balloon catheters, TAVI systems, and structural heart occluders.
Sahajanand Medical Technologies financials
Rs crore · Annual| FY24 | ||
|---|---|---|
| Sales | 902 | |
| Operating Profit | — | |
| OPM % | — | |
| Net Profit | — | |
| Total Debt | 175 |
Sahajanand Medical Technologies IPO offer structure
Offer for sale: ₹475 cr
The offer for sale alone, not the total raise: the document we read does not state the fresh-issue part.
Size and split come from a public aggregator rather than the exchange, cross-checked against a second.
Sahajanand Medical Technologies risks and strengths
- The company is subject to extensive regulatory requirements across geographies, and any non-compliance or failure to maintain approvals could adversely impact operations. (p.20)
- Manufacturing operations face operational risks including quality control issues, equipment failure, and capacity under-utilization. (p.22)
- The company is dependent on third-party suppliers for raw materials and components, with top 10 suppliers contributing significantly to total purchases. (p.26)
Sahajanand Medical Technologies IPO: common questions
What is the Sahajanand Medical Technologies IPO GMP (grey-market premium) today?
As of 15 Oct 2026 the indicative grey-market premium (GMP) for the Sahajanand Medical Technologies IPO is +10.5% across 2 independent grey-market sources. GMP is unregulated and self-reported, so treat it as a sentiment signal, never a guarantee. For context, across the 60 IPOs we have tracked from a pre-listing GMP quote through to the actual listing, grey-market premium pointed the right way 80% of the time. Never decide on GMP alone. Today's GMP for every live IPO →
When does the Sahajanand Medical Technologies IPO open and close?
The Sahajanand Medical Technologies IPO is open for bidding from 15 Oct 2026 to 19 Oct 2026. You can bid on any working day in that window through a broker app or net banking, and a UPI mandate has to be approved by the cut-off time on the closing day. Allotment is fixed on the working day after the close. Open, allotment and listing dates for every IPO →
What is the Sahajanand Medical Technologies IPO price band?
The Sahajanand Medical Technologies IPO price band is ₹327–₹344 per share. You can bid at any price inside the band, and a retail investor can bid at cut-off, which accepts the final issue price, usually the top of the band. The minimum investment is always worked out at that upper end. How book building sets the price →
What is the lot size and minimum investment for the Sahajanand Medical Technologies IPO?
One lot is 43 shares, and a retail application must be at least one lot. An HNI application starts above Rs 2 lakh, so the minimum is higher for that category. Lot size and minimum investment, explained →
When are the Sahajanand Medical Technologies IPO allotment and listing dates?
Not published yet. Derived from the close date on the usual timetable: allotment around 21 Oct 2026, refund/unblock around 22 Oct 2026 and listing around 23 Oct 2026. Treat these as estimates until the exchange confirms them. Allotment and listing dates for every IPO →
How do I apply for the Sahajanand Medical Technologies IPO?
Through any broker app or your bank's net banking, using a demat account and a PAN. You bid in lots at a price inside the band, or at cut-off. The money is blocked in your account, not debited, until allotment. One application per PAN. We do not recommend brokers and carry no broker links. How to apply, start to finish →
How often do these actually open above the issue price?
Of the 538 mainboard IPOs that have listed on the NSE since 2003, 381 (71%) opened above their issue price, at a median of +10%. That is the segment's own record, not a forecast for this issue.
Check it at the source: The offer document · NSE issues · SEBI offer documents
Cite or reuse this data
You're welcome to quote these figures in an article, newsletter or report. Please credit us with a link to this page:
Source: Sahajanand Medical Technologies IPO data, IPO agent by Kredfit, updated 15 Oct 2026. https://ipoagent.kredfit.com/ipo/sahajanand-medical-technologies-limited-502280.htmlSource: <a href="https://ipoagent.kredfit.com/ipo/sahajanand-medical-technologies-limited-502280.html">Sahajanand Medical Technologies IPO data – IPO agent by Kredfit</a> (updated 15 Oct 2026)